Journals / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 2

Distribution of coronary artery risk factors: a regional analysis

Pages
317–324
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, our study continues to emphasize the crucial role of modification of risk factors in patients with coronary artery disease, the most important etiologic factor for morbidity and mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To analyze the frequency and distribution of coronary artery risk factors in the city of Rize and its surrounding areas.
📊
Key Findings & Data:Materials and methods: This observational study included 452 patients (333 men, 119 women).
💡
Conclusion & Impact:Therefore, our study continues to emphasize the crucial role of modification of risk factors in patients with coronary artery disease, the most important etiologic factor for morbidity and mortality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Coronary artery disease · risk factors · regional

Abstract

To analyze the frequency and distribution of coronary artery risk factors in the city of Rize and its surrounding areas. Materials and methods: This observational study included 452 patients (333 men, 119 women). In addition to demographic characteristics of the patients, conventional risk factors were also recorded. The patients were grouped according to their ages, gender, and electrocardiographic characteristics. Results: The mean age of participants was 63 ± 13 years and 74% were male. Smoking and hypertension (HT) were seen more often (71%) in younger male patients. No difference among age groups was detected with regard to the occurrence of diabetes mellitus. The levels of HDL-cholesterol (P < 0.001) and the ratio of total cholesterol to HDL-cholesterol (P < 0.05) were found to be relatively higher in female patients. The prevalence of smoking and familial risk factors both decreased with age. Conclusion: At least one of these risk factors was detected in 97% of patients. Therefore, our study continues to emphasize the crucial role of modification of risk factors in patients with coronary artery disease, the most important etiologic factor for morbidity and mortality.

Özet

To analyze the frequency and distribution of coronary artery risk factors in the city of Rize and its surrounding areas. Materials and methods: This observational study included 452 patients (333 men, 119 women). In addition to demographic characteristics of the patients, conventional risk factors were also recorded. The patients were grouped according to their ages, gender, and electrocardiographic characteristics. Results: The mean age of participants was 63 ± 13 years and 74% were male. Smoking and hypertension (HT) were seen more often (71%) in younger male patients. No difference among age groups was detected with regard to the occurrence of diabetes mellitus. The levels of HDL-cholesterol (P < 0.001) and the ratio of total cholesterol to HDL-cholesterol (P < 0.05) were found to be relatively higher in female patients. The prevalence of smoking and familial risk factors both decreased with age. Conclusion: At least one of these risk factors was detected in 97% of patients. Therefore, our study continues to emphasize the crucial role of modification of risk factors in patients with coronary artery disease, the most important etiologic factor for morbidity and mortality.

🔖

Cite This Article

UYDU, H. A., ATAK, M., ÇANGA, A., TEMİZ, A., ŞATIROĞLU, Ö., KARADAĞ, Z., UĞURLU, Y., ÇİÇEK, Y., BOSTAN, M., BOZKURT, E. (2022). Distribution of coronary artery risk factors: a regional analysis. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 2, 317–324. https://ajindex.com/articles/611307

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. World Health Organization. Th e World Health Report 2002 - Reducing risks to health, promoting healthy life. (http://www. who.int/whr/en) Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. INTERHEART Study Investigators. Eff ect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52. 3. Onat A, Uzunlar B, Hergenç G, Yazıcı M, Uyarel H, Toprak S et al. Distribution of risk variables and global risk across geographic regions of Turkey. Türk Kardiyol Dern Arş 2003; 31: 323-30. Turnbull F. Blood Pressure Lowering Treatment Trialists’ Collaboration. Eff ects of diff erent blood pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet 2003; 362: 1527-35.
  2. Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 2003; 361: 2005-16. 6. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications aft er myocardial infarction: fi nal report of the Lyon Diet Heart Study. Circulation 1999; 99: 779- 85. Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. Th e International Studies of Infarct Survival (ISIS) Collaborators. BMJ 1995; 311: 471-7.
  3. Ermis C, Demir I, Semiz E, Yalcınkaya S, Sancaktar O, Tüzüner FE et al. Antalya Bölgesindeki Koroner Arter Hastalarının Demografi k ve Klinik Özellikleri ve Bu Özelliklerinin Türkiye Ortalamaları ile Karşılaştırılması. Ana Kar Der 2001; 1: 10-13.
  4. Onat A, Karabulut A, Esen AM, Uyarel H, Ozhan H, Albayrak S et al. Analysis of all-cause mortality and coronary events in the Turkish Adult Risk Factor Survey 2005. Turk Kardiyol Dern Ars 2006; 34: 149-53.
  5. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-39. Pyörälä K: CHD prevention in clinical practice. Lancet 1996; 348: 26-8.
  6. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ et al. Prevalence of co